Parent/nurse-controlled analgesia for children with developmental delay.

Area of Science:

• Pediatric Pain Management
• Developmental Pediatrics
• Pharmacology

Background:

• Children with developmental delay often struggle to communicate pain, increasing risks of inadequate pain assessment and management.
• While patient-controlled analgesia (PCA) is effective, not all children can operate it independently.
• Parent/nurse-controlled analgesia (PNCA) presents a potential alternative, but its safety and efficacy require further evaluation.

Purpose of the Study:

• To assess the outcomes of PNCA in pediatric patients diagnosed with developmental delay.
• To evaluate the safety and effectiveness of PNCA for this specific patient population.

Main Methods:

• A retrospective chart review of 71 children with developmental delay who received PNCA.
• Data collection focused on a 72-hour period or until PNCA discontinuation.

Main Results:

• Patients experienced low mean pain scores and required minimal opioid medication for comfort.
• Adverse events were comparable to previous PNCA studies, with oxygen therapy being an exception.
• Somnolence and respiratory depression occurred in 2.8% of patients, necessitating naloxone administration; potential causes were identified.

Conclusions:

• PNCA appears to be an effective strategy for pain control in children with developmental delay.
• Low pain scores and manageable side effects support its utility.
• Close patient monitoring and comprehensive education are critical for ensuring safe PNCA implementation.